| Literature DB >> 29319608 |
Siobhán Stynes1, Kika Konstantinou, Reuben Ogollah, Elaine M Hay, Kate M Dunn.
Abstract
Traditionally, low back-related leg pain (LBLP) is diagnosed clinically as referred leg pain or sciatica (nerve root involvement). However, within the spectrum of LBLP, we hypothesised that there may be other unrecognised patient subgroups. This study aimed to identify clusters of patients with LBLP using latent class analysis and describe their clinical course. The study population was 609 LBLP primary care consulters. Variables from clinical assessment were included in the latent class analysis. Characteristics of the statistically identified clusters were compared, and their clinical course over 1 year was described. A 5 cluster solution was optimal. Cluster 1 (n = 104) had mild leg pain severity and was considered to represent a referred leg pain group with no clinical signs, suggesting nerve root involvement (sciatica). Cluster 2 (n = 122), cluster 3 (n = 188), and cluster 4 (n = 69) had mild, moderate, and severe pain and disability, respectively, and response to clinical assessment items suggested categories of mild, moderate, and severe sciatica. Cluster 5 (n = 126) had high pain and disability, longer pain duration, and more comorbidities and was difficult to map to a clinical diagnosis. Most improvement for pain and disability was seen in the first 4 months for all clusters. At 12 months, the proportion of patients reporting recovery ranged from 27% for cluster 5 to 45% for cluster 2 (mild sciatica). This is the first study that empirically shows the variability in profile and clinical course of patients with LBLP including sciatica. More homogenous groups were identified, which could be considered in future clinical and research settings.Entities:
Mesh:
Year: 2018 PMID: 29319608 PMCID: PMC6485623 DOI: 10.1097/j.pain.0000000000001147
Source DB: PubMed Journal: Pain ISSN: 0304-3959 Impact factor: 7.926
Fig. 1ATLAS study flow diagram (adapted from Konstantinou et al. 2015 Fig. 1 p3 [21])
Monthly response rates to questionnaires
| Month | No. of participants | Follow-up response rate compared to |
|---|---|---|
| 1 | 455 | 74.7% |
| 2 | 410 | 67.3% |
| 3 | 396 | 65.0% |
| 5 | 282 | 46.3% |
| 6 | 325 | 53.4% |
| 7 | 300 | 49.3% |
| 8 | 308 | 50.6% |
| 9 | 286 | 47.0% |
| 10 | 287 | 47.1% |
| 11 | 287 | 47.1% |
Bolded row represent full questionnaires, the rest are short monthly questionnaires on pain severity and disability (RMDQ)
Statistical indices of fit of the latent cluster models of LBLP patients (n=609)
| Number of clusters | BIC | Bootstrapped | Entropy | Smallest sample size |
|---|---|---|---|---|
| 2 | 12101.838 | <0.001 | 0.714 | 281 (46.3) |
| 3 | 12005.723 | <0.001 | 0.738 | 147 (24.1) |
| 4 | 11951.353 | <0.001 | 0.728 | 121 (19.9) |
| 6 | 11974.379 | <0.001 | 0.791 | 51 (8.4) |
| 7 | 12002.221 | <0.001 | 0.802 | 24 (3.9) |
BIC Bayesian Information Criteria; LRT likelihood ratio test.
The number (proportion) of patients in the smallest class; at least 5% of sample should be in each class. The bold text indicates the model selected as having the optimal number of clusters
Fig. 2Five cluster latent class analysis solution. Item response probabilities of categorical variables (left vertical axis) and baseline mean leg and back pain intensity (right vertical axis).
Baseline characteristics of the five clusters of low back- related leg pain patients
| Socio-demographics | Cluster 1 | Cluster 2 | Cluster 3 | Cluster 4 | Cluster 5 | p value |
|---|---|---|---|---|---|---|
| Age (years) mean (SD) | 47.2 (13.8) | 50.4 (13.3) | 50.9 (14.4) | 49.2 (12.7) | 51.9 (14.1) | 0.111 |
| Age category 65+ | 13 (12.5) | 17 (13.9) | 33 (17.6) | 7 (10.1) | 22 (17.5) | 0.238 |
| Gender, Female | 76 (73.1) | 72 (59.0) | 113 (60.1) | 42 (60.9) | 80 (63.5) | 0.187 |
| Current smoker | 27 (26.0) | 29 (23.8) | 52 (27.7) | 30 (43.5) | 56 (44.4) | <0.001 |
| BMI (607) category: | 31 (29.8) | 49 (40.5) | 78 (41.5) | 36 (52.2) | 54 (43.2) | 0.056 |
| Obese/Morbidly obese | ||||||
| Socioeconomic status: Manual | 41 (39.4) | 43 (36.1) | 85 (46.4) | 36 (55.4) | 78 (63.9) | <0.001 |
| occupation (593) | ||||||
| Self-certified time off work (363) | 25 (35.7) | 20 (25.6) | 42 (35.0) | 11 (29.7) | 8 (13.8) | 0.032 |
| or current sick note (365) | 22 (31.4) | 16 (20.3) | 34 (28.3) | 14 (37.8) | 14 (16.2) | 0.279 |
| Back pain duration (607) >6 wks | 64 (61.5) | 72 (59.0) | 117 (62.6) | 47 (68.1) | 89 (71.2) | 0.279 |
| Leg pain duration (583) > 6wks | 50 (50.5) | 52 (45.2) | 105 (57.7) | 38 (57.6) | 87 (71.9) | 0.001 |
| > 3 months | 31 (31.3) | 24 (20.9) | 69 (37.9) | 20 (30.3) | 68 (56.2) | <0.001 |
| >12 months | 15 (15.2) | 10 (8.7) | 24 (13.2) | 3 (4.5) | 29 (24.0) | <0.001 |
| Back pain intensity, mean (SD) | 5.3 (1.7) | 3.4 (1.4) | 5.0 (1.5) | 8.0 (1.3) | 7.5 (1.4) | <0.001 |
| Leg pain intensity, mean (SD) | 3.1 (1.4) | 2.6 (1.2) | 5.5 (1.3) | 8.5 (1.1) | 7.2 (1.4) | <0.001 |
| RMDQ disability score (0-23) | 11.5 (5.6) | 8.6 (5.0) | 12.8 (4.7) | 16.7 (5.1) | 15.1 (5.5) | <0.001 |
| mean (SD) (607) | ||||||
| Sciatica Bothersomeness Index | 11.1 (4.9) | 10.0 (4.4) | 14.7 (4.0) | 19.8 (3.5) | 17.2 (4.4) | <0.001 |
| (0-24)mean (SD) (582) | ||||||
| S-LANSS, possible neuropathic | 37 (35.6) | 44 (36.4) | 100 (53.2) | 45 (66.2) | 67 (53.6) | <0.001 |
| pain (≥12) (606) | ||||||
| STarT Back subgroup (589) | <0.001 | |||||
| Low risk | 17 (17.0) | 44 (37.0) | 16 (13.4) | 0 (0.0) | 5 (4.0) | |
| Medium risk | 52 (52.0) | 59 (49.6) | 105 (58.0) | 20 (30.8) | 40 (32.3) | |
| High risk | 31 (31.0) | 16 (8.8) | 60 (33.1) | 45 (69.2) | 79 (63.7) | |
| Widespread pain | 50 (49.9) | 48 (40.7) | 72 (38.9) | 15 (22.4) | 65 (54.2) | <0.001 |
| HADS Anxiety (607)subscale | ||||||
| Probable | 32 (31.1) | 20 (16.4) | 34 (18.2) | 33 (47.8) | 52 (41.3) | <0.001 |
| HADS Depression subscale | ||||||
| Probable | 12 (11.5) | 9 (7.4) | 21 (11.2) | 26 (37.7) | 30 (23.8) | <0.001 |
| Pain self-efficacy score (0-60), | 37.6 (12.4) | 42.9 (12.5) | 34.7 (12.3) | 22.5 (15.6) | 28.4 (14.3) | <0.001 |
| mean (SD) (593) | ||||||
| EQ—5D-3L summary index (590) | 0.54 (0.3) | 0.66 (0.2) | 0.48 (0.3) | 0.13 (0.3) | 0.29 (0.3) | <0.001 |
| Co-morbidities | ||||||
| Two or more other health | 16 (15.4) | 15 (12.3) | 21 (11.2) | 5 (7.2) | 23 (18.3) | 0.139 |
| problems | ||||||
| General Health (608) | ||||||
| Fair/poor | 38 (36.5) | 31 (25.5) | 59 (31.4) | 32 (47.1) | 62 (49.2) | <0.001 |
| Sleep Disturbance (yes) | 69 (66.3) | 73 (59.8) | 133 (70.7) | 61 (88.4) | 92 (73.0) | 0.001 |
| Clinical diagnosis sciatica | 20 (19.2) | 99 (81.1) | 175 (93.1) | 69 (100.0) | 89 (70.6) | <0.001 |
| Clinician confidence in diagnosis | 72 (69.2) | 75 (61.4) | 156 (83.0) | 63 (91.3) | 70 (55.6) | <0.001 |
| ≥80% | ||||||
| MRI (554) | ||||||
| Clear or possible nerve root | 25 (26.3) | 56 (50.5) | 106 (63.1) | 57 (89.1) | 53 (45.7) | <0.001 |
| compression | ||||||
| Disc prolapse | 17 (68.0) | 47 (83.9) | 84 (79.2) | 49 (86.0) | 33 (62.3) | |
| Stenosis | 6 (24.0) | 7 (12.5) | 19 (17.9) | 7 (12.3) | 16 (30.2) | |
| Other | 2 (8.0) | 2 (3.6) | 3 (2.8) | 1 (1.8) | 4 (7.5) | |
SD, standard deviation; BMI, body mass index; RMDQ, Roland Morris Disability Questionnaire; s-LANSS, self-report Leeds Assessment of Neuropathic Symptoms and Signs; HADS, Hospital Anxiety and Depression Scale; EQ-5D-3L EuroQoL; MRI, magnetic resonance imaging
All figures are frequencies (percentages) unless otherwise stated as mean (SD).
Significance p-value (α=0.05) for the difference between patients in the five latent clusters on ANOVA for continuous variables (Kruskill Wallis for variables BMI, HADS(depression) and EQ-5D) and Chi squared test for categorical variables (Fisher’s exact test for variable socioeconomic cluster and general health).
Denominator varies for some participants due to missing data or non-applicable cases All figures are frequencies (percentages) unless otherwise stated as mean (SD)
Widespread pain derived from the shaded body manikin (defined as pain present above and below the waist in the right and left hand sides of the body and in the axial skeleton).
Score of ≥ 11 indicative of probable depression/anxiety
Question on back and/or leg pain associated sleep disturbance was asked during the clinical assessment.
Other MRI diagnoses (n= 11) included spondylolisthesis, epidural lipomatosis, synovial cyst, osteophyte
Fig. 3Clinical course over 12 months of monthly leg pain intensity scores (0-10) for the five clusters and the clinically diagnosed groups (referred leg pain and sciatica), calculated from the mean of 3 numeric rating scores (NRS) for current and least and usual leg pain over the previous two weeks.
Fig. 4Clinical course over 12 months of disability for the five clusters and the clinically diagnosed groups (referred leg pain and sciatica), measured by the monthly mean Roland Morris Disability Questionnaire (RMDQ) score.
Fig. 5Clinical course over 12 months of monthly back pain intensity scores (0-10) for the five clusters and the clinically diagnosed groups (referred leg pain and sciatica), calculated from the mean of 3 numeric rating scores (NRS) for current and least and usual back pain over the previous two weeks.
Key characteristics for five clusters at 4 and 12 months
| Cluster 1 | Cluster 2 | Cluster 3 | Cluster 4 | Cluster 5 | ||
|---|---|---|---|---|---|---|
| HADS anxiety probable n (%) | Baseline | 32 (31.1) | 20 (16.4) | 34 (18.2) | 33 (47.8) | 52 (41.3) |
| 12 months | 9 (15.0) | 8 (10.3) | 14 (11.7) | 7 (20.0) | 17 (23.6) | |
| HADs depression probable) n (%) | Baseline | 12 (11.5) | 9 (7.4) | 21 (11.2) | 26 (37.7) | 30 (23.8) |
| 12 months | 3 (4.8) | 2 (2.5) | 6 (5.0) | 5 (13.5) | 14 (19.2) | |
| EQ-5D-3L summary index (0-1) mean (SD) | Baseline | 0.54 (0.30) | 0.66 (0.20) | 0.48 (0.30) | 0.13 (0.30) | 0.29 (0.30) |
| 0.73 (0.24) | 0.76 (0.21) | 0.65 (0.29) | 0.49 (0.40) | 0.44 (0.37) | ||
| 0.72 (0.23) | 0.77 (0.21) | 0.68 (0.28) | 0.62 (0.32) | 0.53 (0.38) | ||
| Sciatica bothersomeness index (SBI) (0-24) | Baseline | 11.1 (4.9) | 10.0 (4.4) | 14.7 (4.0) | 19.8 (3.5) | 17.2 (4.4) |
| 4 months | 8.5 (5.2) | 8.5 (4.9) | 10.2 (5.4) | 14.5 (7.0) | 14.3 (5.7) | |
| 12 months | 9.6 (5.4) | 8.2 (4.7) | 10.9 (5.7) | 13.3 (5.6) | 14.1 (6.1) | |
| Pain self-efficacy (PSEQ) 0-60, mean (SD) | Baseline | 37.6 (12.4) | 42.9 (12.5) | 34.7 (12.3) | 22.5 (15.6) | 28.4 (14.3) |
| 4 months | 48.4 (10.7) | 49.1 (12.7) | 42.9 (14.3) | 37.8 (18.4) | 35.8 (17.5) | |
| 12 months | 48.6 (10.1) | 50.0 (11.6) | 44.1 (14.1) | 41.7 (17.7) | 38.4 (17.1) | |
| S-LANSS Neuropathic pain score (≥12) n (%) | Baseline | 37 (35.6) | 44 (36.4) | 100 (53.2) | 45 (66.2) | 67 (53.6) |
| 4 months | 9 (15.3) | 12 (15.6) | 32 (25.4) | 15 (41.7) | 26 (33.3) | |
| 12 months | 8 (13.8) | 10 (13.7) | 31 (27.0) | 10 (28.6) | 20 (29.9) | |
| Global perceived recovery | 4 months | 19 (31) | 37 (46) | 55 (42) | 12 (32) | 16 (19) |
| 12 months | 28 (38) | 42 (45) | 88 (40) | 19 (41) | 22 (27) |
SD, standard deviation; HADS, hospital anxiety and depression scale; EQ-5D-3L, EuroQoL; S-LANSS, self-report Leeds Assessment of Neuropathic Symptoms and Signs
SBI questionnaire only answered by patients whose pain from the back had spread down their legs in the last 2 weeks
compared to 4 (12) months ago, how do you think your back and/or leg pain has changed?